MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$69,690K
Net loss
-$39,227K
Series a preferred
stock conversion...
$18,516K
Deemed dividend
related to seriesb-2...
$11,947K
Loss before income
taxes
-$39,220K
Income tax expense
$7K
Interest income
$555K
Revenue
$45,151K
Loss from operations
-$26,946K
Interest expense
$5,544K
Change in fair value of
sepa, warrant and...
-$4,086K
Change in fair value of
contingent earnout...
$2,743K
Gross profit
$38,186K
Other expense, net
-$456K
Cost of goods sold
$6,965K
Sales and marketing
$28,709K
General and
administrative
$21,458K
Research and development
$14,965K
Back
Back
Income Statement
source: myfinsight.com
TriSalus Life Sciences, Inc. (TLSI)
TriSalus Life Sciences, Inc. (TLSI)